LUNG vs RCEL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 06, 2026

LUNG

33.4
AI Score
VS
RCEL Wins

RCEL

43.4
AI Score

Investment Advisor Scores

LUNG

33score
Recommendation
SELL

RCEL

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LUNG RCEL Winner
Revenue 66.18M 67.07M RCEL
Net Income -32.13M -24.50M RCEL
Gross Margin 77.3% 82.7% RCEL
Net Margin -48.5% -36.5% RCEL
Operating Income -29.50M -18.29M RCEL
ROE -93.9% 78.9% RCEL
ROA -29.2% -52.3% LUNG
Total Assets 110.21M 46.79M LUNG
Cash 52.69M 10.50M LUNG
Debt/Equity 1.11 -1.47 RCEL
Current Ratio 4.05 1.20 LUNG
Free Cash Flow -18.51M -14.52M RCEL

Relative Price Performance (Last 90 Days)

LUNG 1M: +55.6% · 3M: +22.3% RCEL 1M: +32.0% · 3M: +117.4%

Current Technical Phase

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 62

RSI (14): 62.5 · Price: $2.80

RCEL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (26.2% over 20 days), RSI 72

RSI (14): 71.9 · Price: $17.65

Fundamentals Snapshot

Metric LUNG RCEL
Market Cap — —
Forward P/E -3.1 -85.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.5%
Gross Margin 0.8% 0.8%
Operating Margin -0.3% -0.1%
EPS -1.01 -1.21
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RCEL is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.